Making proper judgement when choosing a treatment for actinic keratosis

Expert Review of Dermatology

Volumn 8, Issue 6, 2013, Pages 595-603

  Simon, Jan Christoph ^a   Thiers, Bruce ^b   Augustin, Matthias ^c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

5 fluorouracil; actinic keratosis; cryotherapy; economic evaluation; field cancerization; lesion directed therapy; squamous cell carcinoma; topical treatment

Indexed keywords

DICLOFENAC; FLUOROURACIL; IMIQUIMOD; INGENOL MEBUTATE; RETINOIC ACID; SALICYLIC ACID;

ABLATION THERAPY; ACTINIC KERATOSIS; ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CRYOSURGERY; CRYOTHERAPY; DECISION MAKING; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; HISTORY; HUMAN; LOW DRUG DOSE; PRECANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; TREATMENT PLANNING;

EID: 84887830334     PISSN: 17469872     EISSN: 17469880     Source Type: Journal    
DOI: 10.1586/17469872.2013.856683     Document Type: Article

References (17)

1. Feldman SR, Fleischer AB Jr. Progression of actinic keratosis to squamous cell carcinoma revisited: Clinical and treatment implications. Cutis 87(4), 201-207 (2011
2. Martin G. The impact of the current United States guidelines on the management of actinic keratosis: Is it time for an update? J. Clin. Aesthet. Dermatol. 3(11), 20-25 (2010
3. Criscione VD, Weinstock MA, Naylor MF et al. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer 115(11), 2523-2530 (2009
4. Berman B, Amini S. Pharmacotherapy of actinic keratosis: An update. Expert Opin. Pharmacother. 13(13), 1847-1871 (2012
5. Stockfleth E, Ferrandiz C, Grob JJ et al. Development of a treatment algorithm for actinic keratoses: A European Consensus. Eur. J. Dermatol. 18(6), 651-659 (2008
6. Thai KE, Fergin P, Freeman M et al. A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int. J. Dermatol. 43(9), 687-692 (2004
7. Stockfleth E, Kerl H, Zwingers T, Willers C. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: Histological and clinical study results. Br. J. Dermatol. 165(5), 1101-1108 (2011
8. Stockfleth E, Zwingers T, Willers C. Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses. Eur. J. Dermatol. 22(3), 370-374 (2012
9. Dirschka T, Dominicus R, Lars K, Rodriguez R, Willers C, Simon JC. Long term efficacy and recurrence of topical 0.5% 5-fluorouracil with 10% salicylic acid for actinic keratosis compared to cryotherapy. A prospective, active controlled, randomized, exploratory study. Presented at: 8th European Association of Dermato-Oncology. Barcelona, Spain, 14-17 November 2012, 58 (Poster 91
10. Cohen JL. Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer. J. Clin. Aesthet. Dermatol. 3(6), 39-44 (2010
11. Schaefer I, Augustin M, Spehr C, Reusch M, Kornek T. Prevalence and risk factors of actinic keratoses in Germany-Analysis of multisource data. J. Eur. Acad. Dermatol. Venereol. doi:10.1111/jdv.12102 (2013) (Epub ahead of print
12. Neidecker MV, Davis-Ajami ML, Balkrishnan R, Feldman SR. Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics 27(6), 451-464 (2009
13. Housman TS, Feldman SR, Williford PM et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J. Am. Acad. Dermatol. 48(3), 425-429 (2003
14. Gupta AK. The management of actinic keratoses in the United States with topical fluorouracil: A pharmacoeconomic evaluation. Cutis 70 (2 Suppl.), 30-36 (2002
15. Gold MH. Pharmacoeconomic analysis of the treatment of multiple actinic keratoses. J. Drugs Dermatol. 7(1), 23-25 (2008
16. Colombo GL, Chimenti S, Di Matteo S et al. Cost-effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian health care system. G. Ital. Dermatol. Venereol. 145(5), 573-581 (2010
17. Muston D, Downs A, Rives V. An economic evaluation of topical treatments for actinic keratosis. J. Dermatolog. Treat. 20(5), 266-275 (2009